| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 105.06M | 101.61M | 89.59M | 64.06M | 50.00M | 40.29M |
| Gross Profit | 41.47M | 39.63M | 33.77M | 23.33M | 16.91M | 12.54M |
| EBITDA | 22.98M | 26.34M | 20.45M | 11.69M | 7.55M | 2.79M |
| Net Income | 15.65M | 18.23M | 13.90M | 6.25M | 2.83M | -999.00K |
Balance Sheet | ||||||
| Total Assets | 105.19M | 85.56M | 65.03M | 51.35M | 47.57M | 45.97M |
| Cash, Cash Equivalents and Short-Term Investments | 17.02M | 21.89M | 9.05M | 5.87M | 4.07M | 4.88M |
| Total Debt | 10.42M | 4.25M | 5.45M | 5.86M | 3.15M | 3.96M |
| Total Liabilities | 31.72M | 12.27M | 18.22M | 13.57M | 11.42M | 8.60M |
| Stockholders Equity | 73.47M | 73.29M | 46.80M | 37.78M | 36.15M | 37.37M |
Cash Flow | ||||||
| Free Cash Flow | 14.03M | 6.90M | 9.77M | 7.59M | 4.49M | 6.58M |
| Operating Cash Flow | 16.01M | 9.14M | 10.29M | 8.43M | 5.09M | 7.46M |
| Investing Cash Flow | -10.75M | -2.67M | -518.00K | -843.00K | -599.00K | -860.00K |
| Financing Cash Flow | 6.33M | 6.39M | -6.67M | -5.52M | -5.29M | -4.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £20.56M | 8.38 | 10.60% | 3.22% | 1.64% | ― | |
69 Neutral | £181.77M | 11.35 | 25.14% | 5.32% | 6.38% | -10.55% | |
66 Neutral | £198.64M | 5.82 | 42.11% | 2.65% | -0.89% | 1.30% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | £286.09M | -49.42 | -2.51% | 5.15% | -2.67% | 89.86% | |
39 Underperform | £24.05M | -0.51 | ― | ― | -25.46% | -260.71% |
Warpaint London PLC has appointed Joh. Berenberg, Gossler & Co KG as a joint corporate broker alongside its existing broker, Shore Capital. This strategic move is expected to enhance Warpaint’s market presence and potentially improve its financial advisory capabilities, signaling a commitment to strengthening its position in the cosmetics industry.
The most recent analyst rating on (GB:W7L) stock is a Buy with a £440.00 price target. To see the full list of analyst forecasts on Warpaint London stock, see the GB:W7L Stock Forecast page.
Warpaint London PLC reported an 8% increase in group sales to £49.3 million for the first half of 2025, driven by the acquisition of Brand Architekts and successful new product launches. Despite improved gross profit margins, the company faced a 41% decline in profit before tax due to non-cash losses on foreign exchange contracts and exceptional costs related to the acquisition. The company anticipates a strong second half with significant store rollouts and price increases, although it has lowered its full-year expectations due to challenging market conditions and a key customer entering administration.
The most recent analyst rating on (GB:W7L) stock is a Hold with a £392.00 price target. To see the full list of analyst forecasts on Warpaint London stock, see the GB:W7L Stock Forecast page.
Warpaint London PLC announced that it will release its unaudited interim results for the first half of 2025 on September 10, 2025. This announcement is significant as it follows the company’s recent acquisition of several health and beauty brands, which may impact its market positioning and stakeholder interests.
The most recent analyst rating on (GB:W7L) stock is a Hold with a £392.00 price target. To see the full list of analyst forecasts on Warpaint London stock, see the GB:W7L Stock Forecast page.